OR51E2 and pachyonychia congenita: OR51E2 is present in healthy prostate tissue and shows significantly increased expression in prostate intraepithelial neoplasia (PIN), prostate adenocarcinoma (PC), and castration-resistant prostate cancer (CRPC) (15–22).